Species distribution, virulence factors, and antimicrobial resistance of Acinetobacter spp. isolates from dogs and cats: a preliminary study

Microbiology and Immunology
Yui KimuraMasahisa Watarai

Abstract

We investigated the prevalence of virulence factors and antimicrobial resistance among 67 Acinetobacter spp. isolates, consisting of 21 Acinetobacter baumannii and 46 non-baumannii Acinetobacter from companion animals. The PCR analysis showed that the most prevalent virulence gene was afa/draBC (29.9%), followed by papC (22.4%) and cvaC (20.9%). Antimicrobial susceptibility testing revealed that resistance to gentamicin (14.9%) and ciprofloxacin (11.9%) was relatively prevalent. Five gentamicin- and/or ciprofloxacin-resistant A. baumannii strains were assigned to ST25, ST149, ST164, ST203, and ST1198. All ciprofloxacin-resistant isolates harbored point mutations in gyrA and/or parC. This is the first preliminary monitoring of animal-origin Acinetobacter spp. in Japan.

References

May 1, 1995·Antimicrobial Agents and Chemotherapy·J VilaT Jimenez de Anta
Nov 1, 1993·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·H SeifertG Pulverer
Jun 1, 1997·The Journal of Antimicrobial Chemotherapy·J VilaT Jimenez de Anta
Jun 18, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D H Forster, F D Daschner
Sep 6, 2011·Emerging Infectious Diseases·Sabrina ZordanLenie Dijkshoorn
Sep 22, 2011·The Journal of Antimicrobial Chemotherapy·Vasiliki GogouAthanassios Tsakris
May 10, 2012·FEMS Microbiology Reviews·Michael J McConnellJerónimo Pachón
Dec 1, 2011·Osong Public Health and Research Perspectives·Sunok ParkGyung Tae Chung
Sep 5, 2014·Journal of Medical Microbiology·Kazuki HaradaYasushi Kataoka
Jan 27, 2015·Applied and Environmental Microbiology·Rayane RafeiMarie Kempf
Jun 21, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Hélène PailhorièsMatthieu Eveillard
Jul 19, 2016·International Journal of Antimicrobial Agents·Anaïs HérivauxMarie Kempf
Nov 29, 2016·International Journal of Antimicrobial Agents·Christa EwersSandra Scheufen
Mar 30, 2017·Frontiers in Cellular and Infection Microbiology·Chang-Ro LeeSang Hee Lee
Apr 15, 2017·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yui KimuraShingo Hatoya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.